Nordic News, Business and Life in Asia
AstraZeneca plans to build a cell therapy manufacturing and supply base, as well as an innovation centre, in Shanghai, according to Reuters. The facility will produce CAR-T cell therapies, a …
AstraZeneca aims to be first with full cell therapy capabilities in China Read More
The Anglo-Swedish pharmaceutical concern AstraZeneca is building a US$1.5 billion manufacturing facility in Tuas South, Singapore. This will create over 800 jobs in engineering, technical services, and supply chain …
AstraZeneca breaks ground on Singapore facility, creating 800 jobs Read More
AstraZeneca’s China president, Leon Wang, is now under investigation by Chinese authorities, the company announced in a press release. Earlier this fall, Bloomberg News reported that several current and former …
AstraZeneca’s China president under investigation Read More
Five AstraZeneca employees have been detained by Chinese police, according to Bloomberg News. The arrests are part of an investigation into the illegal import of cancer medication into China. AstraZeneca …
Several AstraZeneca employees arrested in China Read More
AstraZeneca has admitted in court, that their Covid-19 vaccine can cause rare side effects such as blood clots and low platelet count. This was the result of a lawsuit, …
AstraZeneca admits covid-19 vaccine can cause blood clots Read More
The Indonesian Ministry of Health and Team Sweden has launched the Sweden-Indonesia Sustainability Partnership Health Services platform also known as SISP Healthcare Platform. The idea for this new concept was …
Indonesia and Sweden launch Healthcare platform Read More
AstraZeneca Indonesia -the British-Swedish pharmaceutical company – has been chosen as the Best Place to Work in Indonesia for the second year in a row. According to an internal survey, …
AstraZeneca Indonesia voted as best workplace once again Read More
AstraZeneca, the Anglo-Swedish pharmaceutical giant, is building a research and development center in Hong Kong. The new center will be focusing on cell and gene therapy drugs. Set to be …
AstraZeneca to build R&D center in Hong Kong Read More
The Anglo-Swedish pharmaceutical company, AstraZeneca has made a deal with Chinese biotech Usynova. The Chinese company announced a licensing agreement with AstraZeneca for the clinical-stage small molecule KRASG12D inhibitor UA022. …
AstraZeneca makes deal with Chinese biotech Usynova Read More
Anglo-Swedish drug company AstraZeneca announced that it signed a licensing agreement with Eccogene, a Chinese firm for oral medicines which will treat diabetes and obesity on Thursday, 9 November 2023. …
AstraZeneca signs agreement with Chinese firm for oral obesity drug Read More